News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>HSBC Research Upgrades CSPC PHARMA to Buy, Raises TP to HKD9.5
HSBC Global Research has issued a report upgrading CSPC PHARMA (01093.HK)'s rating from Hold to Buy and raising its target price from HKD4.7 to HKD9.5, with the valuation metho...
Reset
Send
The window will close in 5 seconds
<Research>HSBC Research Upgrades CSPC PHARMA to Buy, Raises TP to HKD9.5
Close
Recommend
47
Positive
41
Negative
31
 
SHORT SELL
 
STOCK INFO

HSBC Global Research has issued a report upgrading CSPC PHARMA (01093.HK)  +1.000 (+12.723%)    Short selling $780.41M; Ratio 19.653%   's rating from Hold to Buy and raising its target price from HKD4.7 to HKD9.5, with the valuation method changed from a comprehensive valuation approach to a discounted cash flow estimate, indicating a potential increase of 21%.

According to the report, CSPC PHARMA's revenue/ net profit for 1Q25 decreased by 22%/ 8% YoY, but product sales/ profit increased by 12%/ 60% QoQ, showing a gradual recovery from the pressure of value-based procurement (VBP).
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-06 16:25.)

Related NewsJefferies Downgrades CSPC PHARMA (01093.HK) to Underperform, Adds TP to $5

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.